Modelos de dados selecionados

Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.

111 Resultados da pesquisa.
Relevância Avaliação Novos primeiro Antigos primeiro

Eligibility Cervical Cancer NCT00595725

- 01/08/2016 - 1 Formulário, 2 Grupos de itens, 18 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00595725

Registration Cervical Cancer NCT00262821

- 29/07/2015 - 1 Formulário, 5 Grupos de itens, 27 Elementos de dados, 1 Idioma
Grupos de itens: HEADER MODULE, TRACKING INFORMATION, DEMOGRAPHIC INFORMATION, COMMENTS, FOOTER MODULE
Registration Form, Form R, GOG-0219 Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=EF899EC7-4E6D-0D91-E034-0003BA3F9857

dbGaP phs000723 Sequencing of Cervical Cancer - Eligibility

- 06/01/2023 - 5 Formulários, 1 Grupo de itens, 1 Elemento de dados, 1 Idioma
Grupo de itens: IG.elig
Principal Investigator: Yick Fu Wong, Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA MeSH: Uterine Cervical Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000723 Precision mapping of genetic alterations in cancer can enable better selection of therapies and improved outcomes when combined with new sequencing diagnostics. We describe whole-exome sequences from cervical adenocarcinomas and paired normal samples in Hong Kong Chinese women. These data uncover a heterogeneous genomic landscape but identify commonly aberrant loci including FAT1, ARID1A, ERBB2 and PIK3CA that may provide a focus for the development of individualized targeted therapies for Chinese women with cervical adenocarcinoma.

pht005210.v1.p1

1 Grupo de itens 5 Elementos de dados

pht005211.v1.p1

1 Grupo de itens 5 Elementos de dados

pht005212.v1.p1

1 Grupo de itens 7 Elementos de dados

pht005213.v1.p1

1 Grupo de itens 12 Elementos de dados

Cervical Cancer Cisplatin NCT00064077 GOG - Registration Form

- 15/03/2021 - 1 Formulário, 3 Grupos de itens, 28 Elementos de dados, 1 Idioma
Grupos de itens: HEADER MODULE, TRACKING INFORMATION, Demographic Information
GOG Registration Form - 2058698v3.0 Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix https://clinicaltrials.gov/ct2/show/NCT00064077

Cervical Cancer Cisplatin NCT00064077 GOG - Pathology Form

- 26/06/2017 - 1 Formulário, 3 Grupos de itens, 29 Elementos de dados, 1 Idioma
Grupos de itens: HEADER MODULE, DISEASE ASSESSMENT, SECONDARY DISEASE ASSESSMENT
GOG Pathology Form 2059039v3.0 Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix https://clinicaltrials.gov/ct2/show/NCT00064077

Cervical Cancer Cisplatin NCT00064077 GOG - Follow-Up Form

- 25/06/2017 - 1 Formulário, 7 Grupos de itens, 35 Elementos de dados, 1 Idioma
Grupos de itens: HEADER MODULE, VITAL STATUS, PROGRESSION, BIOMARKERS, NEW PRIMARY, LATE ADVERSE EVENT, NON-PROTOCOL THERAPY
Follow-Up Form - 2059334v3.0 Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix https://clinicaltrials.gov/ct2/show/NCT00064077

Cervical Cancer Cisplatin NCT00064077 GOG - On Study Form

- 24/06/2017 - 1 Formulário, 4 Grupos de itens, 35 Elementos de dados, 1 Idioma
Grupos de itens: HEADER MODULE, Past Medical HISTORY, Medical HISTORY, PRIOR TREATMENT Gynecologic Cancer
GOG Recurrent Gynecologic Cancer - On Study Form Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix On Study Form - 2058732v3.0

Cervical Cancer Cisplatin NCT00064077 GOG - Solid Tumor Evaluation Form

- 24/06/2017 - 1 Formulário, 5 Grupos de itens, 33 Elementos de dados, 1 Idioma
Grupos de itens: HEADER MODULE, TARGET LESION, NON-TARGET LESION, New Lesion Identification, OVERALL RESPONSE
Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix https://clinicaltrials.gov/ct2/show/NCT00064077 Response - GOG Solid Tumor Evaluation Form - 2059416v3.0

Cervical Cancer Cisplatin NCT00064077 GOG - Treatment Completion Form

- 24/06/2017 - 1 Formulário, 3 Grupos de itens, 19 Elementos de dados, 1 Idioma
Grupos de itens: HEADER MODULE, TREATMENT SCHEDULE, OFF-TREATMENT REASON
Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix GOG Treatment Completion Form 2059221v3.0 https://clinicaltrials.gov/ct2/show/NCT00064077

Cervical Cancer Baseline assessment NCT00057928 - Baseline assessment Cervical Cancer NCT00057928 SWOG

- 28/03/2015 - 1 Formulário, 2 Grupos de itens, 15 Elementos de dados, 1 Idioma
Grupos de itens: Header, TARGET LESIONS
SOUTHWEST ONCOLOGY GROUP BASELINE TUMOR ASSESSMENT FORM S0227 Comparison of Cisplatin Combined With Either Paclitaxel or Gemcitabine in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer NCT00057928 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A9C374FF-72CD-367D-E034-0003BA12F5E7

Cervical Cancer Registration SWOG S0227 NCT00057928 - Registration Form Cervical Cancer NCT00057928

- 27/09/2021 - 1 Formulário, 2 Grupos de itens, 29 Elementos de dados, 1 Idioma
Grupos de itens: Header, Patient data
Southwest Oncology Group Registration Form (S0227) S0227 Comparison of Cisplatin Combined With Either Paclitaxel or Gemcitabine in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer NCT00057928 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A9C4563A-B1F7-3ACF-E034-0003BA12F5E7

Enrollment Cervical Cancer ANZGOG-0902 NCT01414608

- 04/08/2015 - 1 Formulário, 7 Grupos de itens, 39 Elementos de dados, 1 Idioma
Grupos de itens: Header, Inclusion Criteria, Laboratory Eligibility Data, Consent, Exclusion Criteria, Stratification Factors, Footer Module
ANZGOG-0902 Enrollment Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=90675395-7527-57AA-E040-BB89AD43454D

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial